How long adults with plaque psoriasis keep taking guselkumab in Romania
Follows adults with plaque psoriasis to see how long they continue guselkumab.
Plain-language title generated from the registry record
Registry title: A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania
Key facts
- Where
- Bârlad, Brasov, Bucharest, Cluj-Napoca, Constanța, Craiova, Iași, Oradea, Reghin, Slatina, Suceava, Târgu-Mures, and Timișoara, RomaniaSee the 20 sites
Where in Romania
- Mihaila G. Georgiana - Cabinet Medical Individual DermatovenerologieBârlad, RomaniaTaking people
- Qualimed SRLBrasov, RomaniaTaking people
- Alin Nicolescu Medic Primar Dermato VenerologieBucharest, RomaniaTaking people
- OptiDerm EstetBucharest, RomaniaTaking people
- Spitalul Clinic ColentinaBucharest, RomaniaTaking people
- Spitalul Clinic Colentina 1Bucharest, RomaniaTaking people
- Spitalul Universitar de Urgenta Elias, Clinica de CardiologieBucharest, RomaniaTaking people
- Ambulator Specialitate Sp Militar de Urgenta Dr Constantin Papilian Cluj NapocaCluj-Napoca, RomaniaTaking people
- Spitalul Clinic Judetean de Urgenta Cluj-NapocaCluj-Napoca, RomaniaTaking people
- Innovative Derm SRLConstanța, RomaniaTaking people
- MC Medica SRLCraiova, RomaniaTaking people
- Policlinica Dr.CorbeanuCraiova, RomaniaTaking people
- Policlinica Top Med Buna VestireCraiova, RomaniaTaking people
- Derma Lux SRLIași, RomaniaTaking people
- Spitalul Clinic Judetean De Urgenta BihorOradea, RomaniaTaking people
- Derma Lux SRL 1Reghin, RomaniaTaking people
- Evaderm Health SRLSlatina, RomaniaTaking people
- Spitalul Judetean de Urgenta 'Sf.Ioan cel Nou', Sectia OncologieSuceava, RomaniaTaking people
- Clinica CabimedTârgu-Mures, RomaniaTaking people
- Dr Tirziu Dermato Chirurgie SRLTimișoara, RomaniaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Janssen Research & Development, LLC
- Trial code
- NCT07582783
- Record updated
- 3 November 2026
- Original description
This study aims to assess the proportion of participants with moderate-to-severe plaque psoriasis who continue treatment with guselkumab over a two-year period.Read full original descriptionShow less
Persistence to Treatment With Guselkumab in Bio-Naive Patients With Moderate-to-Severe Plaque Psoriasis: A Romanian Non-Interventional Multi-center Observational Study
This study aims to assess the proportion of participants with moderate-to-severe plaque psoriasis who continue treatment with guselkumab over a two-year period.
Inclusion: Has a confirmed diagnosis of moderate-to-severe plaque psoriasis; Participant must sign an informed consent form allowing source data verification in accordance with local requirements; Is able to read, understand, and complete the patient reported outcomes (PRO) instruments in local language and comply with completion of all PRO instruments; No previous exposure to biological treatment, including guselkumab (bio-naive patient); Intended for the treatment with guselkumab according to the approved indication.
Exclusion: Current or recent (in the last 30 days prior to first SC dose of guselkumab) participation in any interventional study with investigational product; Meets any of the contraindications according to the latest version of the locally approved summary of product characteristics (SmPC); Is pregnant or lactating; Currently enrolled in another observational study sponsored or managed by a Johnson \& Johnson company.